Botulinum Toxin Market Size, Share and Industry Analysis By Application (Therapeutics, Aesthetics), By End User (Specialty & Dermatology Clinics, Hospitals & Clinics), By Type (Botulinum Toxin Type A, Botulinum Toxin Type B), and Regional Forecast 2020-2029 (Includes COVID-19 Business Impact)

                                          
We have updated Botulinum Toxin Market with respect to COVID-19 Business Impact.
Inquire before buying


This report focuses on the Botulinum Toxin market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Botulinum Toxin market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.


Global Botulinum Toxin Market: Segment Analysis


The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.


Global Botulinum Toxin Market: Regional Analysis


The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.


Global Botulinum Toxin Market: Competitive Landscape


This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.
List of Companies Profiled

  
ALLERGAN
  
Ipsen Pharma
  
Merz Pharma
  
Medytox
  
US WorldMeds, LLC (Solstice Neurosciences, LLC)
  
Galderma laboratories
  
Lanzhou Institute of Biological Products Co., Ltd.
  
Revance Therapeutics, Inc.

Report Coverage

An increasing number of new approvals for indications such as therapeutics and aesthetics are factors leading to increasing demand for new and advanced botulinum toxin products in the global market. Players are focusing on R&D to innovate their product offerings with improved clinical efficiency.

This is projected to lead to an increasing number of new products entering the market during the forecast period. However, comparatively the adverse effects associated with sub-standard botulinum toxin, is one major factor projected to restrain the adoption of these products in emerging countries such as China.

The report provides qualitative and quantitative insights on botulinum toxin industry trends and detailed analysis of market size & growth rate for all possible segments in the market. The botulinum toxin market segments include application, end user, and type. On the basis of application, the market is further segmented into therapeutics (chronic migraine, spasticity, overactive bladder, cervical dystonia, blepharospasm and others) and aesthetics.

On the basis of end user, the market is segmented into specialty & dermatology clinics, hospitals & clinics, and others. On the basis of type, the global market for is segmented into botulinum toxin type A, and botulinum toxin type B. Geographically, the market is segmented into five major regions, which are North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The regions are further categorized into countries.

Along with this, the report analysis comprises of market dynamics and competitive landscape. Additionally, the report offers insights on the Overview of the Number of Injection Procedures by Key Countries, Overview of the Regulatory Scenario by Key Countries, Pricing Analysis, Overview on the Types, Pipeline Analysis, Overview of New Product Launches, Overview of Applications of in Therapeutics and Recent Regulatory Approvals, and Overview of the Reimbursement Scenario by Key Countries.

SEGMENTATION

 

By Application

  
Therapeutics
  
Chronic Migraine
  
Spasticity
  
Overactive Bladder
  
Cervical Dystonia
  
Blepharospasm
  
Others
  
Aesthetics

By End User

  
Specialty & Dermatology Clinics
  
Hospitals & Clinics
  
Others

By Type

  
Botulinum Toxin Type A
  
Botulinum Toxin Type B

By Geography

  
North America (USA and Canada)
  
Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  
Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  
Latin America (Brazil, Mexico and Rest of Latin America)
  
Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Key Industry Developments

  In June 2019, the South Korean company announced the launch of Liztox, a botulinum toxin in Korea for the treatment of moderate to severe glabellar wrinkles
 In February 2019, the U.S. FDA approved Evolus Incs cheaper alternative of botulinum toxin for the treatment of frown lines